The effect of omega-3 supplementation on renal biomarkers in patients with diabetic nephropathy

Phase 3

• Conditions: Diabetic nephropathy.; Diabetes mellitus due to underlying condition with diabetic nephropathy; E08.21

• Registration Number: IRCT20220301054158N1
• Lead Sponsor: Shahre-kord University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 3 April 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with type 1 and type 2 diabetic nephropathy
Fasting blood sugar more than 126 mg/ dl and/ or taking glucose-lowering drugs or insulin
Proteinuria is more than 300 mg per day
Glomerular filtration rate more than 60 ml per minute
Minimum 21 years of age

Exclusion Criteria

Uncontrolled hypertension
Hyperlipidemia
Urinary tract infection
Heart failure
Changing the dose of medication
Taking warfarin
Allergies or omega-3 intolerance

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood creatinine level. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: High-performance liquid chromatography.;Blood urea level. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Enzyme assay.;Urine creatinine. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: High-performance liquid chromatography.;Urine Albumin. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: BCG (Bromocresol Green) Albumin Assay Kit.;Blood pressure. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Manometer.;Glomerular filtration rate. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Using the CKD-EPI formula.